Axsome Therapeutics Class Action Lawsuit AXSM | Deadline July 12, 2022

Axsome Therapeutics, Inc. (AXSM)

The Gross Law Firm notifies investors that a class action has commenced in the United States District Court for the Southern District of New York on behalf of shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM) who purchased shares between December 30, 2019 and April 22, 2022.

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that:

(i) Axsome’s chemistry, manufacturing, and control (“CMC”) practices were deficient with respect to AXS-07, the Company’s medicine for the acute treatment of migraine, and its manufacturing process; (ii) as a result, Axsome was unlikely to submit the AXS-07 New Drug Application (“NDA”) on its initially represented timeline; (iii) the foregoing CMC issues remained unresolved at the time that the U.S. Food and Drug Administration (“FDA”) reviewed the AXS-07 NDA; (iv) accordingly, the FDA was unlikely to approve the AXS-07 NDA; (v) as a result of all the foregoing, Axsome had overstated AXS-07’s regulatory and commercial prospects; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.

Shareholders have until July 12, 2022 to request that the court appoint them lead plaintiff.

To receive more information, please fill out the form.

SUBMIT FORM

Axsome Therapeutics, Inc. Class Action Lawsuit
Axsome Therapeutics, Inc. Lawsuit
AXSM Class Action Lawsuit
AXSM Lawsuit
Axsome Therapeutics, Inc. (AXSM) Class Action Lawsuit